人干细胞来源的小胶质细胞将成为阿尔茨海默病研究必不可少的工具箱
T Liu - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
Alzheimer's disease (AD) is the most common age-related dementia without cures. Between
2000 and 2017, deaths resulting from AD increased 145%. Based on the latest statistical …
2000 and 2017, deaths resulting from AD increased 145%. Based on the latest statistical …
阿尔茨海默病, 神经干细胞和神经发生: 单细胞水平上研究细胞期
MI Cosacak, P Bhattarai, C Kizil - 中国神经再生研究(英文版), 2020 - sjzsyj.com.cn
Alzheimer's disease cannot be cured as of yet. Our current understanding on the causes of
Alzheimer's disease is limited. To develop treatments, experimental models that represent a …
Alzheimer's disease is limited. To develop treatments, experimental models that represent a …
[HTML][HTML] Treating Alzheimer's disease with stem cells: how far have we come?
K Young, S ne Ferreira - Cell and Gene Therapy Insights, 2015 - insights.bio
In 2015, 46.8 million people worldwide have been diagnosed with dementia. This figure is
predicted to rise to 131.5 million people by 2050 [1]. Alzheimer's disease (AD) is the leading …
predicted to rise to 131.5 million people by 2050 [1]. Alzheimer's disease (AD) is the leading …
探索干细胞在阿尔茨海默病的研究前景: 2002–2021 年文献计量分析
李方存， 张鼎， 李梓， 侯召猛， 陈炜， 陈洁… - 中国药学(英文版), 2023 - jcps.bjmu.edu.cn
随着干细胞在阿尔茨海默病的研究越来越多, 这项研究已经成为该领域的研究热点.
干细胞疗法是最具前景的一种治疗方法. 本研究通过文献计量学可视化分析 …
干细胞疗法是最具前景的一种治疗方法. 本研究通过文献计量学可视化分析 …
Advance and challenges in stem cell therapy for Alzheimer's disease
Y Zhang, Y Zhao, X Wang… - Chinese Pharmacological …, 2015 - pesquisa.bvsalud.org
ABSTRACT Alzheimer's disease (AD), the most prevalent type of neurodegenerative
disease, characterized by extracellular β-amyloid (Aβ) plaque deposition, intracellular …
disease, characterized by extracellular β-amyloid (Aβ) plaque deposition, intracellular …
[HTML][HTML] Human stem cell-derived microglia will be an indispensable toolbox for Alzheimer's disease research
T Liu - Neural Regeneration Research, 2021 - journals.lww.com
Alzheimer's disease (AD) is the most common age-related dementia without cures. Between
2000 and 2017, deaths resulting from AD increased 145%. Based on the latest statistical …
2000 and 2017, deaths resulting from AD increased 145%. Based on the latest statistical …
[HTML][HTML] The promise of stem cells in the therapy of Alzheimer's disease
C Yue, N Jing - Translational Neurodegeneration, 2015 - Springer
Abstract Alzheimer's disease (AD), a common neurodegenerative disorder associated with
gradually to dramatic neuronal death, synaptic loss and dementia, is considered to be one of …
gradually to dramatic neuronal death, synaptic loss and dementia, is considered to be one of …
[HTML][HTML] Stem cell therapy for Alzheimer's disease: a scoping review for 2017–2022
Y Duan, L Lyu, S Zhan - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) has been a major causal factor for mortality among elders around
the world. The treatments for AD, however, are still in the stage of development. Stem cell …
the world. The treatments for AD, however, are still in the stage of development. Stem cell …
[HTML][HTML] The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease
C Yue, S Feng, Y Chen, N Jing - Cell Regeneration, 2022 - Springer
Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder associated with
aging. Due to its insidious onset, protracted progression, and unclear pathogenesis, it is …
aging. Due to its insidious onset, protracted progression, and unclear pathogenesis, it is …
New Prospects for Stem Cell Therapy in Alzheimer's Disease
K Jiang, Y Zhu, L Zhang - Hippocampus-Cytoarchitecture and …, 2021 - books.google.com
Alzheimer's disease (AD) is a kind of neurodegenerative disease with insidious onset and
progressive progression. The etiology of AD may be related to the loss of neurons …
progressive progression. The etiology of AD may be related to the loss of neurons …